News

Alnylam price target lowered to $268 from $284 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Alnylam (ALNY) to $268 from $284 and keeps an Equal Weight rating on the shares. The firm is ...
Morgan Stanley Keeps Their Hold Rating on Alnylam Pharma (ALNY)
In a report released today, Michael Ulz from Morgan Stanley maintained a Hold rating on Alnylam Pharma (ALNY – Research Report), with a price ...